NHF12-010

Ask the Expert: Inhibitors

Speakers: Charles Nakar, MD

Issues covered in this session include inhibitor management, immune tolerance induction therapy and eradication of inhibitors. We discuss the latest research findings on immune tolerance induction therapy, patients using rituximab for high-titer inhibitors, and hemophilia A and B patients with high and low titers. Sponsored by Novo Nordisk

MP3

$10.00

$10.00

Subtotal

$10.00